Filing Details
- Accession Number:
- 0001140361-21-020396
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-09 17:25:00
- Reporting Period:
- 2021-06-07
- Accepted Time:
- 2021-06-09 17:25:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610950 | Syneos Health Inc. | SYNH | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260943 | Thomas H. Lee Advisors, Llc | C/O Thomas H. Lee Partners, L.p. 100 Federal Street, 35Th Floor Boston MA 02110 | No | No | No | No | |
| 1665668 | Thl Executive Fund Vii, L.p. | C/O Thomas H. Lee Partners, L.p. 100 Federal Street, 35Th Floor Boston MA 02110 | No | No | No | No | |
| 1713160 | Thl Equity Fund Vii Investors (Inventiv), L.p. | C/O Thomas H. Lee Partners, L.p. 100 Federal Street, 35Th Floor Boston MA 02110 | No | No | No | No | |
| 1713702 | Thl Fund Vii Coinvestment Partners, L.p. | C/O Thomas H. Lee Partners, L.p. 100 Federal Street, 35Th Floor Boston MA 02110 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2021-06-07 | 4,816,880 | $81.20 | 391,991 | No | 4 | S | Indirect | See footnote |
| Class A Common Stock | Disposition | 2021-06-07 | 226,128 | $81.20 | 0 | No | 4 | S | Indirect | See footnote |
| Class A Common Stock | Disposition | 2021-06-07 | 815 | $81.20 | 37 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-06-07 | 313 | $81.20 | 14 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-06-07 | 37 | $81.20 | 0 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-06-07 | 14 | $81.20 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- See Exhibit 99.1 for text of footnote (1).
- See Exhibit 99.1 for text of footnote (2).
- See Exhibit 99.1 for text of footnote (3).
- See Exhibit 99.1 for text of footnote (4).
- See Exhibit 99.1 for text of footnote (5).
- See Exhibit 99.1 for text of footnote (6).
- See Exhibit 99.1 for text of footnote (7).
- See Exhibit 99.1 for text of footnote (8).
- See Exhibit 99.1 for text of footnote (9).
- See Exhibit 99.1 for text of footnote (10).
- See Exhibit 99.1 for text of footnote (11).
- See Exhibit 99.1 for text of footnote (12).
- See Exhibit 99.1 for text of footnote (13).
- See Exhibit 99.1 for text of footnote (14).
- See Exhibit 99.1 for text of footnote (15).
Billionaire Hedge Funds
